Birch triterpenes by Chiesi Farmaceutici for Radiodermatitis: Likelihood of Approval

Birch triterpenes is under clinical development by Chiesi Farmaceutici and currently in Phase II for Radiodermatitis.

Microvascular Diabetes Complications Linked to Moderate/Severe Gum Disease

Certain diabetes complications were linked to moderate and severe periodontitis, a cross-sectional analysis using Danish population-based data suggested. Among nearly 16,000 patients with type 2

September 12, 2024

Pioneering Genomic Progress: An Interview with Rami Mehio, Illumina’s Software and Informatics Expert

In this interview, Rami Mehio, head of software and informatics at Illumina, shares his experiences and contributions to major genomic projects like the UK Biobank’s whole

January 15, 2024

BGI Genomics report: Thailand needs to take urgent action to combat cervical cancer

Only 28.5% of Thai women are diagnosed at stage I of cervical cancer when survival rates are highest, according to a study published by the

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.